II
GOSS icon

Ishara Investments’s Gossamer Bio GOSS Stock Holding History

Ishara Investments’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Hold
820,000
– – 0.1% 41
2026
Q1 		$269K Buy
+820,000
New +$1.29M 0.26% 37

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Ishara Investments's GOSS Position: Q2 2026 in Review

Ishara Investments held its Gossamer Bio (GOSS) position steady in Q2 2026 at 820,000 shares worth $135K. The position accounts for 0.1% of the portfolio, ranked #41.

Ishara Investments first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $269K in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Ishara Investments held 820,000 shares of Gossamer Bio worth $135K as of Q2 2026.
  • Ishara Investments left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up 0.1% of Ishara Investments's portfolio in Q2 2026, its #41 holding.
  • Ishara Investments first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Ishara Investments's Gossamer Bio position peaked at $269K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.